Product Information
OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.1171 per EA under NDC 10702018550. Its NADAC has been published 282 times since Nov 11, 2020.
FDA first approved this application on Feb 9, 2018. Its Orange Book therapeutic-equivalence code is AA.
The High Outlier badge above means this manufacturer's average price in the Oxycodone and Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
325; 5 mg/1; mg/1
Manufacturer
KVK-Tech Inc.NDC
10702018550
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; OXYCODONEApproval Type
Generic (ANDA)
FDA Application
ANDA210644FDA Approved
2/9/2018
TE Code
AA
On Market Since
2/9/2018
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has been published 282 times since Nov 11, 2020, and over the history we have for it it has risen 14.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1171 per EA |
|---|---|
| All-time high | $0.1339 (Apr 16, 2025) |
| All-time low | $0.0815 (Apr 21, 2021) |
| 52-week high | $0.1228 |
| 52-week low | $0.1171 |
| Median price | $0.1046 |
| Average price | $0.1051 |
| Largest weekly change | +17.0% (Nov 20, 2024) |
| Weeks tracked | 282 |
| Tracking since | Nov 11, 2020 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
KVK-Tech Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone and Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, manufactured by KVK-Tech Inc., is $0.1171 per EA (NDC 10702018550), effective Sep 30, 2026.
How has the price of OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has risen 14.0%. It has been tracked across 282 weekly CMS publications since Nov 11, 2020.
What are the highest and lowest recorded NADAC prices for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Since Nov 11, 2020, the NADAC for OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET has ranged from a low of $0.0815 (Apr 21, 2021) to a high of $0.1339 (Apr 16, 2025), with a median of $0.1046 per EA.
Are there cheaper alternatives to OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET, is $0.0864 per EA — about 26% below OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET.
Who manufactures OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET?
OXYCODONE-ACETAMINOPHEN 5-325 MG TABLET (NDC 10702018550) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.